仁和药业
(000650)
| 流通市值：68.97亿 | | | 总市值：72.52亿 |
| 流通股本：13.31亿 | | | 总股本：14.00亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,090,941,027.03 | 1,129,224,010.41 | 3,536,422,014.45 | 2,833,451,760.31 |
| 营业总成本 | 1,670,769,053.24 | 892,993,180.85 | 2,913,953,460.09 | 2,337,881,030.25 |
| 其他经营收益 | | | | |
| 营业利润 | 464,017,658.18 | 243,032,389.65 | 665,212,074.03 | 616,982,001.53 |
| 利润总额 | 464,868,800.17 | 242,906,872.66 | 664,896,992.99 | 616,052,343.95 |
| 净利润 | 355,382,564.49 | 178,229,990.11 | 487,656,749.45 | 469,110,149.21 |
| 每股收益 | | | | |
| 其他综合收益 | -35,537.68 | -20,777.29 | -5,987.04 | - |
| 综合收益总额 | 355,347,026.81 | 178,209,212.82 | 487,650,762.41 | 469,110,149.21 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,236,837,784.85 | 5,159,388,359.69 | 4,944,357,276.78 | 5,222,277,962.93 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,919,719,240.04 | 2,774,547,730.86 | 2,790,761,199.83 | 2,881,522,415.42 |
| 资产总计 | 8,156,557,024.89 | 7,933,936,090.55 | 7,735,118,476.61 | 8,103,800,378.35 |
| 流动负债: | | | | |
| 流动负债合计 | 928,523,101.79 | 784,542,455.45 | 762,756,946.63 | 1,024,792,930.29 |
| 非流动负债: | | | | |
| 非流动负债合计 | 37,703,974.08 | 39,328,256.11 | 40,505,363.81 | 35,469,882.01 |
| 负债合计 | 966,227,075.87 | 823,870,711.56 | 803,262,310.44 | 1,060,262,812.3 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,512,636,487.51 | 6,455,925,808.08 | 6,315,571,807.63 | 6,351,814,041.16 |
| 股东权益合计 | 7,190,329,949.02 | 7,110,065,378.99 | 6,931,856,166.17 | 7,043,537,566.05 |
| 负债和股东权益合计 | 8,156,557,024.89 | 7,933,936,090.55 | 7,735,118,476.61 | 8,103,800,378.35 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,182,069,871.32 | 905,244,506.52 | 4,346,362,181.42 | 3,336,403,499.82 |
| 经营活动现金流出小计 | 1,609,645,691.83 | 780,690,848.9 | 3,495,050,181.52 | 2,495,919,236.69 |
| 经营活动产生的现金流量净额 | 572,424,179.49 | 124,553,657.62 | 851,311,999.9 | 840,484,263.13 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,350,753,255.63 | 2,868,343,038.85 | 11,949,742,452.04 | 6,561,142,389.33 |
| 投资活动现金流出小计 | 7,265,000,717.3 | 4,756,172,447.31 | 12,048,027,596.98 | 8,413,963,211.25 |
| 投资活动产生的现金流量净额 | -1,914,247,461.67 | -1,887,829,408.46 | -98,285,144.94 | -1,852,820,821.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | 0 | 2,405,000 | 80,000 |
| 筹资活动现金流出小计 | 96,622,551.38 | 0 | 307,025,198.66 | 238,342,279.2 |
| 筹资活动产生的现金流量净额 | -96,622,551.38 | 0 | -304,620,198.66 | -238,262,279.2 |
| 汇率变动对现金及现金等价物的影响 | -35,537.68 | -20,777.29 | -9,950.5 | - |
| 现金及现金等价物净增加额 | -1,438,481,371.24 | -1,763,296,528.13 | 448,396,705.8 | -1,250,598,837.99 |
| 期末现金及现金等价物余额 | 1,335,480,007.3 | 1,010,664,850.41 | 2,773,961,378.54 | 1,074,965,834.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -1,438,481,371.24 | - | 448,396,705.8 | - |